Ceftriaxon

DRUG4 trials

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh, Centre Hospitalier Universitaire Vaudois, Bulovka Hospital, International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Conditions

GonorrheaPregnancyShigellosisUrinary Tract InfectionsUrological System Complication of Procedure

Early Phase 1

Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis

RecruitingNCT05761405

Centre Hospitalier Universitaire VaudoisUrinary Tract Infections, Urological System Complication of Procedure

Start: 2024-01-16End: 2026-04-15Target: 90Updated: 2024-02-08

Phase 2

Tebipenem Trial in Children With Shigellosis

Active, not recruitingNCT05121974

International Centre for Diarrhoeal Disease Research, BangladeshShigellosis

Start: 2022-08-18End: 2026-08-17Updated: 2025-08-19

Phase 4

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

CompletedNCT06090565

Bulovka HospitalGonorrhea

Start: 2021-04-01End: 2022-12-22Updated: 2023-10-23

Unknown Phase

Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy

RecruitingNCT07207876

International Maternal Pediatric Adolescent AIDS Clinical Trials GroupPregnancy

Start: 2026-02-16End: 2027-05-17Target: 110Updated: 2026-03-27

Related Papers

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol

BMJ Open2025-02-01

UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract

Trials2024-10-154 citations